Cost of illness of HER2-positive and metastatic and recurrent HER2-positive breast cancer – a Danish register-based study from 2005 to 2016

por Spanggaard, M., Olsen, J., Jensen, K. F., Anderson, M.
Publicado 2022

Methods to identify and characterize developmental neurotoxicity for human health risk assessment. II: neuropathology.

por Garman, R H, Fix, A S, Jortner, B S, Jensen, K F, Hardisty, J F, Claudio, L, Ferenc, S
Publicado 2001